Revenue
€2,597,519
2024 · latest filed year
Employees
33
2026-06
Average wage
€6,469
monthly, before tax
Tax arrears
No recorded arrears
No data
Company overview
AI researchA source-linked overview of the company's activities based on public information.
A Kaunas-registered IQVIA research and development company conducting medical-science research and applied work within the global clinical-research group.
Products and services
Sources
Researched: 24 August 2026 · Confidence: High · This overview was prepared by AI. Verify important claims with the linked primary sources.
Registry information
- Company code
- 300612865
- Legal form
- Private Limited Liability Company
- Status
- No legal proceedings
- Registered
- 2 November 2006
- Municipality
- —
- Registered office
- Kaunas, Savanorių pr. 349, LT-51480
- Office registered since
- 2 November 2006
- Office data updated
- 7 August 2026
Insolvency proceedings
Official AVNT company bankruptcy and restructuring data. Administrator identities and contact details are not shown.
- Active proceeding
- No
- Proceedings on record
- 0
VAT information
- VAT registered
- Yes
- VAT number
- LT100002885519
- VAT registered on
- 21 February 2007
- Of which overdue
- €0
Primary activity
- EVRK code
- 721940
- Primary activity
- Not provided
- Employees
- 33 (2026-06)
- Average wage
- €6,469
Participant structure
Only aggregate participant counts are published, without personal data.
- Total participants
- 1
- Lithuanian natural persons
- 0
- Lithuanian legal persons
- 0
- Foreign natural persons
- 0
- Foreign legal persons
- 1
- Has foreign participants
- Yes
Online presence
A website and its published information are shown only after its link to the legal entity is verified.
No verified company website has been found yet.
Tax and public procurement
A summary of taxes paid from VMI and contracts published by the Public Procurement Office.
- Taxes paid year to date
- €256,681
- Reporting period
- June 2026
- Public contracts
- 0
- Total contract value
- —
- Latest contract
- —
Financials
Key figures from the company's filed annual financial statements.
| Year | Revenue | Profit before tax | Net profit | Total assets | Equity |
|---|---|---|---|---|---|
| 2024 | €2,597,519 | €190,250 | €158,587 | €734,902 | €332,720 |
| 2023 | €2,641,654 | €233,152 | €195,997 | €1,019,595 | €574,134 |
| 2022 | €2,693,455 | €222,736 | €185,603 | €880,231 | €628,136 |
| 2021 | €2,355,849 | €174,863 | €146,023 | €990,622 | €692,533 |
| 2020 | €2,080,125 | €161,933 | €134,830 | €1,041,773 | €746,510 |
| 2019 | €2,134,538 | €172,893 | €142,371 | €1,950,005 | €1,611,680 |
Filed: 23 April 2025
Similar companies
Active companies in the same sector, ranked by latest revenue.
Scientific research and development
- UAB Biotechnologinės farmacijos centras "Biotechpharma"€74,035,286
- UAB "Biosantara"€74,035,286
- Nacionalinis vėžio institutas€46,373,001
- Baltic Champs, UAB€31,051,154
- UAB "Lietuvos cukraus fabrikas"€26,039,332
- Uždaroji akcinė bendrovė "Biomapas"€22,744,500
- MB "Matučiukai"€20,210,326
- UAB "LT Biotech"€14,452,601
Sources: State Enterprise Centre of Registers, VMI, Sodra and the Public Procurement Office. Website ownership is checked against .lt domain data and legal-entity details published on the website. Open data is licensed under CC BY 4.0.